Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy
- PMID: 17620480
- DOI: 10.1001/archneur.64.9.noc60125
Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy
Abstract
Background: Single-voxel magnetic resonance spectroscopy measurements of N-acetyl aspartate, choline, and creatine (Cr) are affected in patients with human immunodeficiency virus (HIV) and neurocognitive impairment. However, these metabolic markers are often normalized in affected central nervous system regions, such as the lenticular nuclei, after initiation of highly active antiretroviral therapy (HAART).
Objective: To examine whether lactate (Lac), a marker of inflammation and anaerobic glycolysis, and lipid, an indicator of cell membrane turnover resulting from oxidative stress, could serve as surrogate biomarkers within the lenticular nuclei of HIV-positive patients with different degrees of neurocognitive impairment.
Design: Three-tesla 2-dimensional-chemical shift imaging magnetic resonance spectroscopy at echo times of 30 milliseconds and 135 milliseconds was performed in voxels overlapping the lenticular nuclei of seronegative controls and a spectrum of HIV-positive patients (neurocognitively normal, mildly impaired, or moderately to severely impaired).
Setting: University of Pennsylvania, Philadelphia.
Participants: Ten seronegative controls and 45 HIV-positive patients with different degrees of neurocognitive impairment (15 neurocognitively normal patients, 12 mildly impaired patients, and 18 moderately to severely impaired patients).
Main outcome measures: In vivo 2-dimensional-chemical shift imaging magnetic resonance spectroscopy analysis of N-acetyl aspartate:Cr, choline:Cr, Lac:Cr, and (lipid + Lac):Cr ratios among the various groups. In addition, the effect of the degree of HAART central nervous system penetration (high vs low) on these ratios was studied.
Results: No significant lenticular nuclei atrophy was detected with volumes similar across all of the groups. Both N-acetyl aspartate:Cr and choline:Cr ratios were similar across all of the groups at either echo time. In contrast, the Lac:Cr ratio was significantly greater in HIV-positive patients with moderate to severe impairment compared with seronegative controls. The (lipid + Lac):Cr ratio was significantly elevated within each HIV-positive subgroup compared with seronegative controls. Within HIV-positive patients receiving HAART, the degree of central nervous system penetration (high vs low) did not affect metabolic ratios.
Conclusions: As seen with 2-dimensional-chemical shift imaging magnetic resonance spectroscopy, HIV induces inflammation and oxidative stress in HIV-positive patients despite HAART. Lipid and Lac are more sensitive inflammatory biomarkers that may be used to differentiate HIV-positive subgroups. However, no significant difference in efficacy, as measured by metabolic ratios, exists for high- vs low-central nervous system-penetrating HAART.
Similar articles
-
A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.Neuroimage. 2004 Dec;23(4):1336-47. doi: 10.1016/j.neuroimage.2004.07.067. Neuroimage. 2004. PMID: 15589098 Clinical Trial.
-
Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children.J Magn Reson Imaging. 2008 Apr;27(4):710-7. doi: 10.1002/jmri.21251. J Magn Reson Imaging. 2008. PMID: 18383256
-
Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV - 1H MRS evaluation.Med Sci Monit. 2004 Jun;10 Suppl 3:101-6. Med Sci Monit. 2004. PMID: 16538209
-
[Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)].Fortschr Neurol Psychiatr. 2005 Oct;73(10):577-86. doi: 10.1055/s-2004-830283. Fortschr Neurol Psychiatr. 2005. PMID: 16217698 Review. German.
-
Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments.Clin Neuropathol. 2001 Jul-Aug;20(4):146-55. Clin Neuropathol. 2001. PMID: 11495003 Review.
Cited by
-
Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND).Curr HIV/AIDS Rep. 2022 Oct;19(5):344-357. doi: 10.1007/s11904-022-00612-2. Epub 2022 Jul 22. Curr HIV/AIDS Rep. 2022. PMID: 35867211 Free PMC article. Review.
-
Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study.J Neurovirol. 2010 Feb;16(1):76-82. doi: 10.3109/13550280903493914. J Neurovirol. 2010. PMID: 20053142 Clinical Trial.
-
Heme oxygenase-1 dysregulation in the brain: implications for HIV-associated neurocognitive disorders.Curr HIV Res. 2014;12(3):174-88. doi: 10.2174/1570162x12666140526122709. Curr HIV Res. 2014. PMID: 24862327 Free PMC article. Review.
-
Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.Crit Rev Immunol. 2013;33(4):307-59. doi: 10.1615/critrevimmunol.2013007247. Crit Rev Immunol. 2013. PMID: 23971529 Free PMC article. Review.
-
Review of functional MRI in HIV: effects of aging and medication.J Neurovirol. 2017 Feb;23(1):20-32. doi: 10.1007/s13365-016-0483-y. Epub 2016 Oct 7. J Neurovirol. 2017. PMID: 27718211 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials